Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.
2.

Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.

Papakostas GI, Nutt DJ, Hallett LA, Tucker VL, Krishen A, Fava M.

Biol Psychiatry. 2006 Dec 15;60(12):1350-5. Epub 2006 Aug 24. Review.

PMID:
16934768
3.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
5.

Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.

Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, Lerer B, Fava M.

Int Clin Psychopharmacol. 2009 Jan;24(1):19-25. doi: 10.1097/YIC.0b013e328314dfaf. Review.

PMID:
19092448
7.

Bupropion: a review of its use in the management of major depressive disorder.

Dhillon S, Yang LP, Curran MP.

Drugs. 2008;68(5):653-89. Review. Erratum in: Drugs. 2008;68(7):980.

PMID:
18370448
8.

Use of bupropion in combination with serotonin reuptake inhibitors.

Zisook S, Rush AJ, Haight BR, Clines DC, Rockett CB.

Biol Psychiatry. 2006 Feb 1;59(3):203-10. Epub 2005 Sep 13. Review.

PMID:
16165100
9.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
10.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
11.

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.

Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.

Int J Clin Pract. 2007 Aug;61(8):1337-48. Review.

PMID:
17627710
12.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
14.

The efficacy and tolerability of bupropion in the treatment of major depressive disorder.

Moreira R.

Clin Drug Investig. 2011 Oct 19;31 Suppl 1:5-17. doi: 10.2165/1159616-S0-000000000-00000. Review.

PMID:
22015858
15.

[Fluoxetine: an update of its use in major depressive disorder in adults].

Gourion D, Perrin E, Quintin P.

Encephale. 2004 Jul-Aug;30(4):392-9. Review. French.

PMID:
15597466
16.

Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.

Mukai Y, Tampi RR.

Clin Ther. 2009 May;31(5):945-61. doi: 10.1016/j.clinthera.2009.05.016. Review.

PMID:
19539096
17.

Spotlight on bupropion in major depressive disorder.

Dhillon S, Yang LP, Curran MP.

CNS Drugs. 2008;22(7):613-7. Review.

PMID:
18547129
18.

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

Smith D, Dempster C, Glanville J, Freemantle N, Anderson I.

Br J Psychiatry. 2002 May;180:396-404. Review.

19.

Symptoms of fatigue and sleepiness in major depressive disorder.

Baldwin DS, Papakostas GI.

J Clin Psychiatry. 2006;67 Suppl 6:9-15. Review.

20.

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group.

J Clin Psychiatry. 2008 Sep;69(9):1404-15. Review.

PMID:
19193341

Supplemental Content

Support Center